OMER
USDOmeros Corporation Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$7.060
उच्च
$7.240
कम
$6.710
मात्रा
1.29M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
458.0M
उद्योग
जैव प्रौद्योगिकी
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
3.30M
एक्सचेंज
NGM
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's experimental drug, which is being developed for rare blood and kidney disorders, they said on Wednesday.
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros' clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rare Disease portfolioOmeros is eligible to receive 340 million US dollars in upfront and near-term
संबंधित स्टॉक
DCOM
Dime Community Bancshares Inc.
ENX
Eaton Vance New York Municipal Bond Fund Common Shares of Beneficial Interest $.01 par value
IVCP
Swiftmerge Acquisition Corp. Ordinary Share
SIRI
Sirius XM Holdings Inc.
IMMP
Immutep Limited American Depositary Shares
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।